INBX — Inhibrx Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Inhibrx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	11.5	129	131	274	278
Net Total Accounts Receivable
Net Total Receivables	0.438	0.615	0.878	0.257	0.778
Prepaid Expenses
Total Current Assets	15.6	132	139	280	295
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10.7	11.3	9.49	7.22	9.37
Other Long Term Assets
Total Assets	26.5	144	150	291	308
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	20.6	31.4	22.5	27.6	56.3
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	60.6	68.3	98.1	233	264
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-34.1	75.5	52.4	58.1	43.5
Total Liabilities & Shareholders' Equity	26.5	144	150	291	308
Total Common Shares Outstanding